SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.0604
-0.0016 (-2.58%)
At close: Jan 30, 2026
SoftOx Solutions AS Revenue
SoftOx Solutions AS had revenue of 4.46M NOK in the quarter ending September 30, 2025, with 214.74% growth. This brings the company's revenue in the last twelve months to 13.59M, up 795.26% year-over-year. In the year 2024, SoftOx Solutions AS had annual revenue of 7.91M with 13.38% growth.
Revenue (ttm)
13.59M
Revenue Growth
+795.26%
P/S Ratio
10.73
Revenue / Employee
6.79M
Employees
2
Market Cap
145.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.91M | 934.00K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | 9.84M | 5.74M | 140.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 109.99M |
| Aqua Bio Technology ASA | 101.51M |
| Nykode Therapeutics AS | 73.37M |
| Arctic Bioscience AS | 45.90M |
| PCI Biotech Holding ASA | 4.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |
| Zelluna ASA | 53.00K |